Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study.

Cancers (Basel) · 2020 · PMC7352575 · PMID 32585901

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The median PFS was numerically superior in the triplet arm (16 months) compared to the doublet arm (10 months), but the difference did not reach statistical significance [ 24 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.